4.7 Article

PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation

期刊

DEVELOPMENTAL CELL
卷 54, 期 3, 页码 317-+

出版社

CELL PRESS
DOI: 10.1016/j.devcel.2020.06.013

关键词

-

资金

  1. CRUK [C588/A19167, C8216/A6129, C588/A10721]
  2. NIH [CA83115]
  3. MRC Career Development award [MR/S007644/1]
  4. Simons Initiative for the Developing Brain [SFARI 529085]
  5. MRC HGU studentship
  6. NIH Intramural Research Program
  7. Wellcome Trust [098051, 206194, 208402/Z/17/Z]
  8. ERC [694289]
  9. Cancer Biology [R01 CA103846]
  10. NIH Melanoma PPG [P01CA63222]
  11. Melanoma Research Alliance
  12. Starr Cancer Consortium grant
  13. MRC HGU Programme [MC_UU_00007/9]
  14. European Research Council [ZF-MEL-CHEMBIO-648489]
  15. L'Oreal-Melanoma Research Alliance [401181]
  16. MRC [MR/K017047/1, MC_UU_00007/9, MR/S007644/1] Funding Source: UKRI
  17. European Research Council (ERC) [694289] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Melanocytes, replenished throughout life by melanocyte stem cells (MSCs), play a critical role in pigmentation and melanoma. Here, we reveal a function for the metastasis-associated phosphatase of regenerating liver 3 (PRL3) in MSC regeneration. We show that PRL3 binds to the RNA helicase DDX21, thereby restricting productive transcription by RNAPII at master transcription factor (MITF)-regulated endolysosomal vesicle genes. In zebrafish, this mechanism controls premature melanoblast expansion and differentiation from MSCs. In melanoma patients, restricted transcription of this endolysosomal vesicle pathway is a hallmark of PRL3-high melanomas. Our work presents the conceptual advance that PRL3-mediated control of transcriptional elongation is a differentiation checkpoint mechanism for activated MSCs and has clinical relevance for the activity of PRL3 in regenerating tissue and cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据